About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 201 record(s)
Req # A-2022-001355
Adverse Drug Reactions (ADRs) for . Report numbers: E2B_05933342, 001018852. ADRs for PANTOPRAZOLE SODIUM. Report numbers: E2B_05917203, E2B_05917057, E2B_05906789, E2B_05916968, E2B_05925115. ADRs for AMPHETAMINE ASPARTATE MONOHYDRATE / AMPHETAMINE SULFATE / DEXTROAMPHETAMINE SACCHARATE / DEXTROAMPHETAMINE SULFATE. Report numbers: 001018915, 001017866. ADR for MEZAVANT. Report number: 001018374.Organization: Health Canada
March 2023
Req # A-2022-001360
Adverse Drug Reaction (ADR) for ZOSTAVAX II. Report number: 000687988. ADR for ONCOTICE. Report number: 000914673. ADRs for PNEUMOVAX 23. Report numbers: 000664078, E2B_01976711, E2B_02617912, E2B_00506085, E2B_02617883, E2B_00179953, E2B_01976711, E2B_02617912.Organization: Health Canada
March 2023
Req # A-2022-001386
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075320-264.Organization: Health Canada
March 2023
Req # A-2022-001387
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107980-705.Organization: Health Canada
March 2023
Req # A-2022-001406
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-110432-515, What We Heard Report During the 2022 Consultations on the Targeted Review of the Pest Control Products Act.Organization: Health Canada
March 2023
Req # A-2022-001409
Adverse Drug Reaction (ADR). Report number: 000722991.Organization: Health Canada
March 2023
Req # A-2022-001430
Adverse Drug Reactions (ADRs). Report numbers: 001022579, 001023009, 001023011, 001023018, 001023036.Organization: Health Canada
March 2023
Req # A-2022-001433
Adverse Drug Reaction (ADR). Report number: 000997976.Organization: Health Canada
March 2023
Req # A-2022-001434
Adverse Drug Reaction (ADR) for SOLIRIS. Report number: E2B_05935628.Organization: Health Canada
March 2023
Req # A-2022-001438
Adverse Drug Reaction (ADR). Report number: E2B_05886951.Organization: Health Canada
March 2023